For instance, compulsory fees for drug prescription in the Czech Republic and Hungary, a new pharmaceutical pricing scheme in Slovakia, and mandatory labelling of all medicaments in Cyrillic alphabet in Bulgaria, will adversely affect the market in the short-term ... These measures imply an additional cost pressure either on consumers or drug-manufacturers and will have an adverse effect on the development of pharmaceutical markets in these countries.